| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Product sales | 2.369 | 2.447 | 2.129 | 2.179 |
| Cost of sales | 1.048 | 0.927 | 0.992 | 0.974 |
| General and administrative | 0.789 | 0.905 | 0.892 | 0.816 |
| Selling and marketing | 0.28 | 0.286 | 0.273 | 0.292 |
| Research and development | 0.158 | 0.162 | 0.187 | 0.187 |
| Total operating expenses | 2.275 | 2.28 | 2.344 | 2.269 |
| Income (loss) from operations | 0.094 | 0.167 | -0.215 | -0.09 |
| Interest expense | 0.001 | 0.002 | 0.003 | 0.035 |
| Interest expense - related party | 0.036 | 0.036 | 0.038 | - |
| Total other expense, net | -0.037 | -0.038 | -0.041 | -0.035 |
| Net income (loss) | 0.057 | 0.129 | -0.256 | -0.125 |
| Undistributed earnings allocated to participating securities | 0.028 | 0.062 | - | - |
| Net income (loss) attributable to common stockholders | 0.029 | 0.067 | - | -0.125 |
| Earnings per share, basic, total | 0 | 0.01 | -0.03 | -0.02 |
| Earnings per share, diluted, total | 0 | 0.01 | -0.03 | -0.02 |
| Weighted average number of shares outstanding, basic, total | 8,004,389 | 8,004,389 | 8,004,389 | 8,004,389 |
| Weighted average number of shares outstanding, diluted | 8,167,297 | 8,004,389 | 8,004,389 | 8,004,389 |
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)